ArticleSleep & breathing = Schlaf & Atmung2026
Sleep-disordered breathing in patients with heart failure with preserved left ventricular ejection fraction.
Article in Sleep & breathing = Schlaf & Atmung, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A pilot study to assess a novel screening questionnaire for central sleep apnea in patients undergoing overnight diagnostic polysomnography.Sleep & breathing = Schlaf & Atmung · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeData on sleep-disordered breathing (SDB) in patients with heart failure with preserved left ventricular ejection fraction (HFpEF) are sparse. Therefore, we aimed to determine the prevalence and characteristics of SDB in a large patient cohort with HFpEF.
methodsA total of 233 patients with HFpEF were prospectively enrolled at our cardiology outpatient department after excluding patients with a history of SDB. The presence of moderate to severe SDB with an apnea-hypopnea index ≥ 15/h was determined using cardiorespiratory polygraphy. All patients underwent assessment of HFpEF comorbidities, comprehensive echocardiographic studies, NT-proBNP levels and calculation of HFpEF-scores.
resultsSDB was found in 97 of 233 patients (42%) with predominantly obstructive sleep apnea (OSA) in 64 patients (27%) and predominantly central sleep apnea (CSA) in 33 patients (14%). Male sex, body mass index, NYHA heart failure class III, NT-proBNP levels, HFpEF scores, chronic kidney disease, coronary artery disease, left ventricular (LV) mass index and E/E' ratio by echocardiography were significant predictors of SDB by univariate analysis. Patients with predominantly CSA were significantly older and had higher NT-proBNP levels and a higher NYHA heart failure class than patients with OSA. Patients with OSA had a significantly higher body mass index (BMI) and a higher Epworth Sleepiness score. Multivariate analysis revealed male gender, BMI and LV mass index as significant predictors for OSA, whereas CSA was associated with a higher HFA-PEFF score and male gender.
conclusionsModerate to severe SDB is a frequent comorbidity in patients with HFpEF. Predominantly OSA is more frequent than CSA with significant clinical differences between patients with OSA compared to CSA. Whereas OSA is associated with a higher BMI in addition to male gender, CSA is associated with more advanced heart failure as indicated by higher HFA-PEFF scores, NYHA heart failure class and NT-proBNP levels.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.